RxDoctor Payments Data

Nicolle Digerolamo-Thaller, APRN

Family · Statesboro, GANPI 1881873099

Payments from drug & device makers

$332in general payments, 2019–2025

Across 18 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar, Inc.$79
  • Sumitomo Pharma America, Inc.$56
  • Mindray DS USA, Inc.$48
  • Bayer$40
  • Accord Healthcare, Inc.$20
  • C. R. Bard, Inc. & Subsidiaries$18
  • plus $70 from 5 others

What the payments were for

  • Food & beverage$332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$332 in reported general payments places this provider in the 45th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$35,601
Medicare patients
213
Services billed
697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron63$39,516
GemtesaVibegron43$33,284
PremarinEstrogens, Conjugated14$6,123
Estradiol64$4,564
NitrofurantoinNitrofurantoin Macrocrystal89$2,174
Tamsulosin Hcl131$1,955
Solifenacin Succinate41$1,395
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst80$1,208
Finasteride59$1,133
Oxybutynin Chloride ErOxybutynin Chloride25$524
Methenamine Hippurate11$437
Potassium Citrate ErPotassium Citrate11$427
Cephalexin60$376
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim36$351
Clobetasol Propionate12$233

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$14$39,51663 claims
Sumitomo Pharma America, Inc.Gemtesa$56$33,28443 claims
PfizerPremarin$14$6,12314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,258 family providers in Georgia.

Other family in Statesboro

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →